WHO SMART Guidelines - HIV
0.3.0 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Official URL: http://smart.who.int/hiv/Library/HIVIND72Logic | Version: 0.3.0 | |||
Draft as of 2024-08-18 | Computable Name: HIVIND72Logic |
% of people who tested positive for gonorrhoea during the reporting period
Generated Narrative: Library HIVIND72Logic
Depends On | Library HIC | http://smart.who.int/hiv/Library/HIVCommon|0.0.1 |
Depends On | Library WCom | WHOCommon |
Measurement Period | in | 0 | 1 | Period |
Patient | out | 0 | 1 | Patient |
Initial Population | out | 0 | 1 | boolean |
Numerator | out | 0 | 1 | boolean |
Denominator | out | 0 | 1 | boolean |
text/cql
/**
* Library: HIV.IND.72 Logic
* Ref No: STI.5A
* Short Name: Gonorrhoea test positivity, HIV prevention services
*
* Definition: % of people who tested positive for gonorrhoea during the reporting period
*
* Numerator: Number of people attending HIV prevention services who tested positive for gonorrhoea during the reporting period
* Numerator Calculation: COUNT of clients with "Gonorrhoea test date" in the reporting period AND "Gonorrhoea test result"='Positive'
* Numerator Exclusions:
*
* Denominator: Number of people attending HIV prevention services tested for gonorrhoea (using a molecular test, culture or POC test) during the reporting period
* Denominator Calculation: COUNT of clients with "Gonorrhoea test date" on "Date accessed HIV prevention intervention" in the reporting period
* Denominator Exclusions:
*
* Disaggregations:
* • Gender (male, female, other*)
* • Age (15–19, 20–24, 25–29, 30–49, 50+ years)
* • Key populations (men who have sex with men, people living in prisons and other closed settings, people who inject drugs, sex workers, trans and gender diverse people)**
* • HIV status (HIV-positive, HIV-negative, unknown status)
* • HIV prevention intervention (for example, PrEP)
* • Diagnostic test used and anatomic site sampled
* • Cities and other administrative regions of epidemiologic importance
*
* Disaggregation Elements: Gender | Age | Key population member type | HIV status | HIV prevention intervention | Type of specimen | Neisseria gonorrhoeae test type
*
* Numerator and Denominator Elements:
* Date accessed HIV prevention intervention
* Gonorrhoea test date
* Gonorrhoea test result
*
* Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
*
* Data Concepts:
* HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
* HIV.A.DE18: Gender* | Gender of the client*
* HIV.A.DE19: Female | Client identifies as female
* HIV.A.DE20: Male | Client identifies as male
* HIV.A.DE21: Transgender male | Client identifies as transgender male
* HIV.A.DE22: Transgender female | Client identifies as transgender female
* HIV.A.DE23: Other | Additional category
* HIV.B.DE50: Key population member type* | The type of key population that the client is included in
* HIV.B.DE51: Sex worker | Client is a sex worker
* HIV.B.DE52: Men who have sex with men | Client is a man who has sex with men
* HIV.B.DE53: Trans and gender-diverse people | Client identifies as trans and gender-diverse
* HIV.B.DE54: People who inject drugs | Client is a person who injects drugs
* HIV.B.DE55: People living in prisons and other closed settings | Client lives in a prison or another closed setting
* HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
* HIV.B.DE116: HIV-positive | Client is HIV-positive
* HIV.B.DE117: HIV-negative | Client is HIV-negative
* HIV.B.DE118: Unknown | Client has unknown HIV status
* HIV.B.DE255: Gonorrhoea test date | Date of Gonorrhoea test
* HIV.B.DE256: Gonorrhoea test result | Result from Gonorrhoea test
* HIV.B.DE257: Positive | Test result is positive for Neisseria gonorrhoeae
* HIV.B.DE258: Negative | Test result is negative for Neisseria gonorrhoeae
* HIV.B.DE259: Inconclusive | Test result is inconclusive
* HIV.B.DE261: Type of specimen | Type of specimen to be collected
* HIV.B.DE262: Blood | Blood specimen to be collected
* HIV.B.DE263: Urine | Urine specimen to be collected
* HIV.B.DE264: Cervical or vaginal swab | Cervical or vaginal swab to be collected
* HIV.B.DE265: Urethral or penile swab | Urethral or penile swab to be collected
* HIV.B.DE266: Rectal swab | Rectal swab to be collected
* HIV.B.DE267: Other | Other specimen type to be collected
* HIV.B.DE276: Neisseria gonorrhoeae test type | Type of diagnostic test used for Neisseria gonorrhoeae
* HIV.B.DE277: NAAT | Nucleic Acid Amplification Test (NAAT) used
* HIV.B.DE278: POC Test | Point-of-care (POC) test used
* HIV.B.DE279: Culture | Culture test used
* HIV.B.DE280: Microscopy | Microscopy test used
* HIV.B.DE281: Other | Other type of test used
* HIV.D.DE807: Gonorrhoea test date | Date of Gonorrhoea test
* HIV.D.DE808: Gonorrhoea test result | Result from Gonorrhoea test
* HIV.D.DE809: Positive | Test result is positive for Neisseria gonorrhoeae
* HIV.D.DE810: Negative | Test result is negative for Neisseria gonorrhoeae
* HIV.D.DE811: Inconclusive | Test result is inconclusive
* HIV.D.DE813: Type of specimen | Type of specimen to be collected
* HIV.D.DE814: Blood | Blood specimen to be collected
* HIV.D.DE815: Urine | Urine specimen to be collected
* HIV.D.DE816: Cervical or vaginal swab | Cervical or vaginal swab to be collected
* HIV.D.DE817: Urethral or penile swab | Urethral or penile swab to be collected
* HIV.D.DE818: Rectal swab | Rectal swab to be collected
* HIV.D.DE819: Other | Other specimen type to be collected
* HIV.D.DE828: Neisseria gonorrhoeae test type | Type of diagnostic test used for Neisseria gonorrhoeae
* HIV.D.DE829: NAAT | Nucleic Acid Amplification Test (NAAT) used
* HIV.D.DE830: POC Test | Point-of-care (POC) test used
* HIV.D.DE831: Culture | Culture test used
* HIV.D.DE832: Microscopy | Microscopy test used
* HIV.D.DE833: Other | Other type of test used
* HIV.E.DE114: Key population member type* | The type of key population that the infant's mother is included in
* HIV.E.DE115: Sex worker | Infant's mother is a sex worker
* HIV.E.DE116: People who inject drugs | Infant's mother is a person who injects drugs
* HIV.E.DE117: Trans and gender-diverse people | Infant's mother identifies as trans and gender-diverse
* HIV.E.DE118: People living in prisons and other closed setting | Infant's mother is in a prison or closed setting
* HIV.PRV.DE2: HIV prevention intervention | HIV prevention intervention that client accessed
* HIV.PRV.DE3: PrEP service | Client accessed PrEP services
* HIV.PRV.DE4: OAMT | Client accessed opioid agonist maintenance treatment (OAMT) services
* HIV.PRV.DE5: NSP | Client accessed needle-syringe programme (NSP) services
* HIV.PRV.DE6: STI services | Client accessed sexually transmitted infection (STI) services
* HIV.PRV.DE7: VMMC | Client accessed voluntary medical male circumcision (VMMC) services
* HIV.PRV.DE8: Other | Client accessed other HIV prevention services
* HIV.PRV.DE10: Date accessed HIV prevention intervention | Date the client accessed HIV prevention intervention
*
* Additional Context
* - what it measures: A: % of people attending HIV prevention services who were tested for gonorrhoea and | had a positive test result during the reporting period | B: % of people living with HIV who were tested for gonorrhoea and had a positive test result during the reporting period
* - rationale: • Gonorrhoea test positivity can be used to highlight areas within a country that require additional support and provide early warning of potential changes in HIV and sexually transmitted infection transmission in the general population. | • Gonorrhoea test positivity is important information for generating national, regional and global incidence and prevalence estimates for gonorrhoea. | • Data on gonorrhoea test positivity are important for understanding the challenges imposed by increasing resistance to currently recommended treatment options.
* - method: Individual-level data obtained from programme records. | | If individual-level data are not available, the indicator can be reported using aggregate programme data.
*
* Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
*/
library HIVIND72Logic
// Included Libraries
using FHIR version '4.0.1'
include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom
// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]
context Patient
/* Populations */
/*
*Initial Population
*/
define "Initial Population":
true
/**
* Numerator
*
* Definition: Number of people attending HIV prevention services who tested positive for gonorrhoea during the reporting period
* Calculation: COUNT of clients with "Gonorrhoea test date" in the reporting period AND "Gonorrhoea test result"='Positive'
*/
define "Numerator":
true
/**
* Denominator
*
* Definition: Number of people attending HIV prevention services tested for gonorrhoea (using a molecular test, culture or POC test) during the reporting period
* Calculation: COUNT of clients with "Gonorrhoea test date" on "Date accessed HIV prevention intervention" in the reporting period
*/
define "Denominator":
true
/* end Populations */
Content not shown - (
application/elm+xml
, size = 15Kb )